137 related articles for article (PubMed ID: 30075982)
1. Prevalence and risk factors for fosfomycin resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.
Ramos J; Bastida MT; Niño E; Smithson A
Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(7):484-485. PubMed ID: 30075982
[No Abstract] [Full Text] [Related]
2. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections].
Junquera S; Loza E; Baquero F
Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):197-201. PubMed ID: 15826543
[TBL] [Abstract][Full Text] [Related]
3. [Involvement of bacterial resistances in community-acquired urinary infections].
Horcajada JP; Fariñas Mdel C
Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):1-3. PubMed ID: 15701324
[No Abstract] [Full Text] [Related]
4. Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.
Chervet D; Lortholary O; Zahar JR; Dufougeray A; Pilmis B; Partouche H
Med Mal Infect; 2018 May; 48(3):188-192. PubMed ID: 29054298
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.
Smithson A; Chico C; Ramos J; Netto C; Sanchez M; Ruiz J; Porron R; Bastida MT
Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):423-30. PubMed ID: 21761126
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants.
Hernández Marco R; Guillén Olmos E; Bretón-Martínez JR; Giner Pérez L; Casado Sánchez B; Fujkova J; Salamanca Campos M; Nogueira Coito JM
Enferm Infecc Microbiol Clin; 2017 May; 35(5):287-292. PubMed ID: 26976379
[TBL] [Abstract][Full Text] [Related]
7. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
Manges AR; Johnson JR; Foxman B; O'Bryan TT; Fullerton KE; Riley LW
N Engl J Med; 2001 Oct; 345(14):1007-13. PubMed ID: 11586952
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications. In vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
[No Abstract] [Full Text] [Related]
9. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
10. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.
Burman WJ; Breese PE; Murray BE; Singh KV; Batal HA; MacKenzie TD; Ogle JW; Wilson ML; Reves RR; Mehler PS
Am J Med; 2003 Oct; 115(5):358-64. PubMed ID: 14553870
[TBL] [Abstract][Full Text] [Related]
11. An epidemic of urinary tract infections?
Stamm WE
N Engl J Med; 2001 Oct; 345(14):1055-7. PubMed ID: 11586959
[No Abstract] [Full Text] [Related]
12. Increasing in vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
[No Abstract] [Full Text] [Related]
13. [Susceptibility to antibiotics of Escherichia coli isolated from community-acquired urinary tract infections].
Fabre R; Mérens A; Lefebvre F; Epifanoff G; Cerutti F; Pupin H; Tardif D; Cavallo JD; Ternois I
Med Mal Infect; 2010 Oct; 40(10):555-9. PubMed ID: 20417046
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
15. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
[TBL] [Abstract][Full Text] [Related]
17. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
20. In vitro resistance of E coli to TMP/SMX and clinical failure.
Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
